Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) traded up 7.7% during trading on Friday . The stock traded as high as 4.04 and last traded at 3.90. 263,130 shares were traded during trading, a decline of 96% from the average session volume of 6,251,881 shares. The stock had previously closed at 3.62.
Mind Medicine (MindMed) Company Profile (NASDAQ:MNMD)
Mind Medicine (MindMed) Inc, a psychedelic medicine biotech company, discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances, including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC.
Receive News & Ratings for Mind Medicine (MindMed) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mind Medicine (MindMed) and related companies with MarketBeat.com's FREE daily email newsletter.